IL-4R-alpha drugs for Chronic Obstructive Pulmonary Disease
4 tracked IL-4R-alpha drugs in the Chronic Obstructive Pulmonary Disease race. The class explanation lives on the IL-4R-alpha page; the full indication pipeline across every mechanism is on the Chronic Obstructive Pulmonary Disease page.
1 approved / phase 41 Phase 2/31 Phase 21 preclinical / unstaged
Head-to-head evidence: APG808 vs dupilumab · dupilumab vs Rademikibart · dupilumab vs stapokibart